Form 8-K Elevance Health, Inc. For: Jul 17
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Elevance (ELV) PT Raised to $585 at RBC Capital
July 18, 2024 6:13 AM EDTRBC Capital analyst Ben Hendrix raised the price target on Elevance (NYSE: ELV) to $585.00 (from $575.00) while maintaining a Outperform rating.
The analyst comments "We believe ELV shares are oversold on known temporary Medicaid mix headwinds (which should ease over the next 612 months) and DCP optics... More
Morgan Stanley Reiterates Overweight Rating on Elevance (ELV)
July 17, 2024 8:28 AM EDTMorgan Stanley analyst Erin Wright reiterated an Overweight rating and $643.00 price target on Elevance (NYSE: ELV).
The analyst comments "Pre-Call View - ELV Shares Should Grind higher on Consolidated MLR Beat: While we await conf. call granularity on underlying cost trends by line of business, however, the... More
Truist Securities Reiterates Buy Rating on Elevance (ELV)
July 17, 2024 8:28 AM EDTTruist Securities analyst David MacDonald reiterated a Buy rating and $620.00 price target on Elevance (NYSE: ELV).
The analyst comments "First Read Solid 2Q With MLR A Bit Better, Strong Growth At Carelon, FY Guidance Reaffirmed. ELV reported solid 2Q results featuring in-line revenues, MLR that was modestly better than our/consensus estimates and adjusted EPS also topped expectations with FY guidance of at least $37.20 reaffirmed. Operating revenue of $43.22B was roughly in-line with our $43.24BE and consensus $43.05B... More
